0000000000009579

AUTHOR

Andreas Pfützner

showing 13 related works from this author

Endothelial Function and Arterial Stiffness in Uncomplicated Type 1 Diabetes and Healthy Controls and the Impact of Insulin on These Parameters durin…

2007

BACKGROUND In addition to its role in glucose metabolism, insulin has shown to exert numerous vascular effects, and an impaired vascular function of insulin is assumed to be a major contributor in the development of vascular complications. Arterial augmentation (AP) and the augmentation index (Aix) are surrogate parameters of arterial stiffness and are commonly used as predictors for cardiovascular risk. The aim of this study is to investigate the effect of insulin on arterial stiffness and parameters of endothelial function in patients with type 1 diabetes and healthy control subjects. METHODS Fourteen patients with type 1 diabetes (six male, eight female) with a mean age of 36.6 +/- 11.8 …

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBiomedical EngineeringBioengineering030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDiabetes mellitusInternal medicineInternal MedicinemedicineNeurological and Microvascular FunctionType 1 diabetesbusiness.industryInsulinNitrotyrosineLitermedicine.diseasePulse pressureEndocrinologychemistryArterial stiffnessAsymmetric dimethylargininebusinessJournal of Diabetes Science and Technology
researchProduct

Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at car…

2007

We investigated the effect of pioglitazone in comparison with and in combination with simvastatin on insulin resistance, plasma adiponectin, postprandial plasma glucose, insulin, and intact proinsulin levels in a nondiabetic population at cardiovascular risk. One hundred twenty-five nondiabetic patients at cardiovascular risk were randomized to pioglitazone (PIO), pioglitazone and simvastatin (PIO/SIM), or simvastatin (SIM) treatments. Blood samples were taken for the measurement of adiponectin and lipid levels. In addition, an oral glucose load with the measurements of glucose, insulin, and intact proinsulin levels was performed. Adiponectin levels increased from 14.0 ± 8.2 to 27.6 ± 14.5 …

Simvastatinmedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationEndocrinologyInsulin resistanceDouble-Blind MethodRisk FactorsInternal medicineInsulin SecretionHumansHypoglycemic AgentsInsulinMedicineProspective StudieseducationProinsulineducation.field_of_studyPioglitazoneAdiponectinbusiness.industryInsulinnutritional and metabolic diseasesGlucose Tolerance Testmedicine.diseasePostprandialEndocrinologyCardiovascular DiseasesSimvastatinThiazolidinedionesAdiponectinInsulin ResistancebusinessPioglitazoneProinsulinmedicine.drugMetabolism
researchProduct

Peripheral Leptin Levels in Narcoleptic Patients

2007

Narcolepsy is a severe sleep disorder that in most patients is characterized by the deficiency of central orexin. Clinically, narcolepsy is associated with obesity. Currently, there is a literature controversy about the potential alteration of leptin levels in narcoleptic patients. Theoretically, diminished leptin levels could partially contribute to the observed overweight of patients. Two studies have reported decreased leptin levels, whereas a larger, recent study failed to detect differences between patients and controls.To help settle the controversy, we have measured peripheral leptin levels in 42 narcoleptic patients and in 31 body mass index-matched controls.No significant differenc…

AdultLeptinMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmacromolecular substancesBody Mass IndexEndocrinologyReference ValuesDiabetes mellitusInternal medicineHumansMedicineAgedNarcolepsySleep disorderbusiness.industryLeptinMiddle Agedmedicine.diseaseObesityPeripheralOrexinMedical Laboratory TechnologyEndocrinologynervous systemFemalebusinessNarcolepsyDiabetes Technology & Therapeutics
researchProduct

Pilot study for the evaluation of morphological and functional changes in retinal blood flow in patients with insulin resistance and/or type 2 diabet…

2012

Background: The aim of this study was to investigate early morphological and functional pathology in the retinal micro-circulation in patients with insulin resistance and/or type 2 diabetes mellitus (T2DM). Methods: Fifty-four subjects, without features of retinopathy under ophthalmological investigation, were recruited for study participation and were classifed into three study groups according to their metabolic staging: (1) Group C comprised nondiabetic, insulin-sensitive subjects with a BMI <28kg/m2; (2) Group IR comprised nondiabetic, insulin-resistant, obese subjects with a BMI ≥28 kg/m2; and (3) Group DM comprised patients with manifested T2DM. Retinal microvascular blood flow was…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineeringPilot Projectschemistry.chemical_compoundInsulin resistanceRetinal DiseasesInternal medicineOphthalmologyDiabetes mellitusInternal MedicineLaser-Doppler FlowmetryMedicineHumansObesityFluorescein AngiographyAgedDiabetic Retinopathymedicine.diagnostic_testbusiness.industryType 2 Diabetes MellitusRetinal VesselsRetinalBlood flowLaser Doppler velocimetryMiddle Agedmedicine.diseaseFluorescein angiographyEndocrinologyCross-Sectional StudiesEarly DiagnosischemistryDiabetes Mellitus Type 2Regional Blood FlowFemaleOriginal ArticleInsulin ResistancebusinessRetinopathyJournal of diabetes science and technology
researchProduct

Influence of glucose control and improvement of insulin resistance on microvascular blood flow and endothelial function in patients with diabetes mel…

2005

The study was performed to investigate the effect of improving metabolic control with pioglitazone in comparison to glimepiride on microvascular function in patients with diabetes mellitus type 2.A total of 179 patients were recruited and randomly assigned to one treatment group. Metabolic control (HbA1c), insulin resistance (HOMA index), and microvascular function (laser Doppler fluxmetry) were observed at baseline and after 3 and 6 months.HbA1c improved in both treatment arms (pioglitazone: 7.52 +/- 0.85% to 6.71 +/- 0.89%, p.0001; glimepiride: 7.44 +/- 0.89% to 6.83 +/- 0.85%, p.0001). Insulin-resistance decreased significantly in the pioglitazone group (6.15 +/- 4.05 to 3.85 +/- 1.92, p…

AdultBlood GlucoseMalemedicine.medical_specialtyEndotheliumPhysiologyArbitrary unitInsulin resistancePhysiology (medical)Diabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsMolecular BiologyAgedPioglitazonebusiness.industryMicrocirculationGlucose clamp techniqueMiddle Agedmedicine.diseaseGlimepirideEndocrinologymedicine.anatomical_structureSulfonylurea CompoundsDiabetes Mellitus Type 2Metabolic control analysisGlucose Clamp TechniqueFemaleThiazolidinedionesEndothelium VascularInsulin ResistanceCardiology and Cardiovascular MedicinebusinessPioglitazoneBlood Flow Velocitymedicine.drugMicrocirculation (New York, N.Y. : 1994)
researchProduct

Elevated peripheral visfatin levels in narcoleptic patients.

2008

OBJECTIVE: Narcolepsy is a severe sleep disorder that is characterized by excessive daytime sleepiness, cataplexies and a tendency towards obesity. Recent discoveries indicate that the major pathophysiology is a loss of hypocretin (orexin) producing neurons due to immunologically mediated degeneration. Visfatin is a recently described proinflammatory adipokine. It is identical to the immune modulating pre-B-cell colony enhancing factor (PBEF). Our study examines the hypothesis that visfatin levels are altered in narcoleptic patients. METHODS: For the analysis, a total of n = 54 patients (n = 18 males and n = 36 females) with the diagnosis of narcolepsy according to DSM-IV and the Internatio…

AdultMalemedicine.medical_specialtyPolysomnographyNicotinamide phosphoribosyltransferaseAdipokineExcessive daytime sleepinesslcsh:MedicinePolysomnographyBody Mass IndexProinflammatory cytokineDiabetes and Endocrinology/Obesitychemistry.chemical_compoundReference ValuesInternal medicinemedicineHumansHLA-DR2 AntigenAge of OnsetNicotinamide Phosphoribosyltransferaselcsh:ScienceAgedNarcolepsySleep disorderMultidisciplinarymedicine.diagnostic_testbusiness.industrylcsh:RMiddle Agedmedicine.diseaseOrexinEndocrinologyMental Health/Sleep Disordersnervous systemchemistryImmunologyCytokinesFemalelcsh:Qmedicine.symptomImmunology/Genetics of the Immune SystembusinessResearch ArticleNarcolepsyPLoS ONE
researchProduct

Dose escalating safety study of CNS 5161 HCl, a new neuronal glutamate receptor antagonist (NMDA) for the treatment of neuropathic pain

2007

What is already known about this subject • Despite encouraging effects of N-methyl-D-aspartate (NMDA) receptor antagonists in reducing neuropathic pain of different aetiologies, the clinical use of these agents has been limited by their mainly psychotropic side-effects. • In a recent study in healthy volunteers, CNS 5161, a novel noncompetetive NMDA receptor antagonist, was well tolerated up to a dosage of 2000 µg without psychotropic side-effects. • This is the first study to evaluate the maximal tolerated dosage of CNS 5161 and to gain experience about the analgesic effect of CNS 5161 in patients with different pain syndromes. What this study adds • In patients with neuropathic pain CNS 5…

AdultMaleVisual analogue scaleAnalgesicPlaceboGuanidinesReceptors N-Methyl-D-Aspartatechemistry.chemical_compoundDrug SafetyDouble-Blind MethodMedicineHumansPharmacology (medical)Glutamate receptor antagonistSulfhydryl CompoundsAdverse effectAgedPain MeasurementPharmacologyCross-Over StudiesDose-Response Relationship Drugbusiness.industryTherapeutic effectMiddle AgedBlood pressurechemistryAnesthesiaNeuropathic painNeuralgiaFemalebusiness
researchProduct

Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk.

2008

We investigated the effect of atorvastatin monotherapy and combined treatment with atorvastatin and pioglitazone on intima-media thickness, vascular function and the cardiovascular risk profile. In all, 148 patients (76 male, 72 female; aged 61.4±6.5 years; body mass index [BMI] 29.2±4.1 kg/m2; mean±SD) with increased cardiovascular (CV) risk factors were randomised. Intima-media thickness (IMT), the augmentation index (Aix@75), the microvascular response to acetylcholine (LDF), lipid status, and plasma levels of intact proinsulin, adiponectin, interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1), matrix metalloproteinase-9 (MMP-9), sCD40L, P-selectin, tissue plasminogen activator …

MaleEndocrinology Diabetes and MetabolismAtorvastatinBlood lipidsBlood Pressurechemistry.chemical_compoundGermanyAtorvastatinMedicineProspective StudiesSkinUltrasonographyeducation.field_of_studymedicine.diagnostic_testMiddle AgedLipidsTreatment OutcomeCardiovascular DiseasesRadial ArteryDrug Therapy CombinationFemaleInflammation MediatorsCardiology and Cardiovascular Medicinemedicine.drugmedicine.medical_specialtyCarotid Artery CommonPopulationRisk AssessmentDouble-Blind MethodInternal medicineInternal MedicineHumansPyrroleseducationAgedAdiponectinPioglitazonebusiness.industryCholesterolMicrocirculationAtherosclerosisEndocrinologychemistryHeptanoic AcidsThiazolidinedionesHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessLipid profilePioglitazoneLipoproteinDiabetesvascular disease research
researchProduct

Retinal Microcirculation in Type 1 Diabetic Patients With and Without Peripheral Sensory Neuropathy

2014

In patients with diabetes mellitus (DM), early retinal microvascular alterations can be observed even before the clinical diagnosis of diabetic retinopathy. This study aimed to investigate morphological and functional changes in retinal microvascular blood flow in type 1 diabetic patients with and without peripheral neuropathy (PNP) as compared to nondiabetic controls. Retinal microvascular blood flow (RBF) was assessed using scanning laser Doppler flowmetry (Heidelberg Retina Flowmeter, Heidelberg Engineering, Germany) before and after stimulation with flicker light. PNP was assessed using the neuropathy disability score (NDS) and by the evaluation of the vibration perception threshold (V…

inorganic chemicalsmedicine.medical_specialtyEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineering-chemistry.chemical_compoundVibration perceptionMedizinische FakultätDiabetes mellitusOphthalmologyInternal Medicinemedicineheterocyclic compoundsddc:610RetinaType 1 diabetesbusiness.industryRetinalBlood flowDiabetic retinopathyOriginal Articlesmedicine.diseaseSurgeryenzymes and coenzymes (carbohydrates)Peripheral neuropathymedicine.anatomical_structurechemistrybusiness
researchProduct

Evaluation of CGMS® During Rapid Blood Glucose Changes in Patients with Type 1 Diabetes

2006

CGMS (Medtronic Minimed, Duesseldorf, Germany) allows continuous glucose monitoring. Recent studies with invasive monitoring techniques revealed discrepancies in blood glucose measurements obtained from different anatomical sites compared with those from the fingertip. The aim of this study was to investigate the CGMS and a device for alternative site testing (AST) during dynamic blood glucose changes and to compare these results with fingertip measurements.Twelve patients with type 1 diabetes (seven women, five men; age, 33.3 +/- 8.7 years) received a 75-g oral glucose load. Insulin was applied intravenously (rapid glucose decline) or subcutaneously (moderate glucose decline) in a dosage b…

AdultBlood GlucoseMalemedicine.medical_specialtyInjections SubcutaneousEndocrinology Diabetes and Metabolismmedicine.medical_treatmentEndocrinologyForearmDiabetes mellitusmedicineHumansHypoglycemic AgentsInsulinIn patientBlood Glucose MeasurementType 1 diabetesbusiness.industryBlood Glucose Self-MonitoringSite testingInsulinGlucose MeasurementMiddle Agedmedicine.diseaseSurgeryMedical Laboratory TechnologyDiabetes Mellitus Type 1medicine.anatomical_structureAnesthesiaInjections IntravenousFemalebusinessDiabetes Technology & Therapeutics
researchProduct

Investigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index?

2011

Alice Engel1,2, Jana Helfrich1, Nina Manderscheid1, Petra B Musholt3, Thomas Forst3, Andreas Pfützner3, Norbert Dahmen1,21Department of Psychiatry, University of Mainz, Germany; 2Fachklinik Katzenelnbogen, Katzenelnbogen, Germany; 3IKFE, Institute for Clinical Research and Development, Mainz, GermanyBackground: Narcolepsy is a severe sleep-wake cycle disorder resulting in most cases from a lack of orexin, the energy balance-regulating hormone. Narcoleptic patients have been reported to suffer from an excess morbidity of Type 2 diabetes, even after correction for their often elevated body mass index.Methods: To explore whether narcolepsy is specifically associated with a propensity …

insulinobesitymedicine.medical_specialtyPathologyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmentnarcolepsyNeurosciences. Biological psychiatry. NeuropsychiatryType 2 diabetesInsulin resistanceInternal medicinemedicineintact proinsulinRC346-429Biological PsychiatryOriginal ResearchProinsulinbusiness.industryInsulinmedicine.diseaseOrexinPsychiatry and Mental healthEndocrinologyHomeostatic model assessmentNeurology. Diseases of the nervous systemfasting glucosebusinessBody mass indexRC321-571NarcolepsyNeuropsychiatric Disease and Treatment
researchProduct

Increased Arterial Augmentation and Augmentation Index as Surrogate Parameters for Arteriosclerosis in Subjects with Diabetes Mellitus and Nondiabeti…

2007

Background: Arterial augmentation (AP) and the augmentation index (Aix) are surrogate parameters of arterial stiffness and are commonly used as predictors for cardiovascular risk. The aim of this study is to compare these parameters in diabetic subjects and nondiabetic cardiovascular risk subjects with healthy control subjects. Methods: One hundred sixty-six nonsmoking subjects aged between 35 and 70 years were included in the study, which included 100 subjects with cardiovascular disease but not diabetes (mean age 62.73±8.75 years), 33 subjects with type 2 diabetes (66.58±2.69 years), and 33 healthy controls (51.89±8.91 years). In these subjects, arterial stiffness was measured by the diff…

Neurological and Microvascular Functionmedicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismBiomedical EngineeringCentral pressure030209 endocrinology & metabolismBioengineeringMean ageArteriosclerosisDiseaseType 2 diabetesmedicine.disease03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineHealthy controlInternal MedicinemedicineArterial stiffnessCardiology030212 general & internal medicinebusinessJournal of Diabetes Science and Technology
researchProduct

Impact of insulin on microvascular blood flow and endothelial cell function in the postprandial state in patients with Type 1 diabetes.

2005

The aim of the present study was to investigate postprandial microvascular blood flow following a standardized test meal in nondiabetic subjects and in patients with Type 1 diabetes after regular insulin or insulin lispro. In this open-label, randomised cross-over study, 20 nondiabetic participants and 20 patients with Type 1 diabetes were enrolled. To valuate the postprandial time course of skin microvascular blood flow, laser Doppler flux (LDF) readings were obtained at baseline and every 30 min following a standardized test meal. Furthermore, the microvascular response to acetylcholine (Ach) was measured, and blood was collected for the measurement of serum insulin and blood glucose leve…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismArbitrary unitmedicine.medical_treatmentEndocrinologyReference ValuesDiabetes mellitusInternal medicineInternal MedicinemedicineInsulin lisproHumansHypoglycemic AgentsInsulinSkinType 1 diabetesCross-Over StudiesInsulin Lisprobusiness.industryInsulinMicrocirculationBlood flowmedicine.diseasePostprandial PeriodAcetylcholinePostprandialEndocrinologyDiabetes Mellitus Type 1Regular insulinFemaleEndothelium VascularbusinessBlood Flow Velocitymedicine.drugJournal of diabetes and its complications
researchProduct